demonstrated total ATM loss in 8% of colorectal carcinoma samples, (25) whilst it was found in 14% of prostate carcinoma cases by Antonarakis et al., (26) and ATM loss reached 41% in lung adenocarcinoma cases according to Villaruz et al. This evidence concerns the gene ATM and colorectal carcinoma.